Results 271 to 280 of about 36,128 (286)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Lancet, The, 2021
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi   +2 more
exaly  

Global reanalysis: goodbye ERA-Interim, hello ERA5

2019
Hersbach, Hans, Bell, W, Berrisford, Paul, Horányi, Andras, J., Muñoz-Sabater, Nicolas, J., Radu, Raluca, Schepers, Dinand, Simmons, Adrian, Soci, Cornel, Dee, Dick   +10 more
openaire   +1 more source

Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement

Ca-A Cancer Journal for Clinicians, 2020
Daniel J Lenihan, Joseph Carver, Charles Porter   +2 more
exaly  

Skalierung von ERA-Interim Daten in komplexem Terrain

2023
Gao, Lu, Härer, Stefan, Bernhardt, Matthias, Schulz, Karsten   +3 more
openaire   +1 more source

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

Lancet, The, 2022
Ayan Dey
exaly  

Clinical trials in the era of personalized oncology

Ca-A Cancer Journal for Clinicians, 2011
Richard L Schilsky
exaly  

A new era of cancer immunotherapy: converting theory to performance

Ca-A Cancer Journal for Clinicians, 1999
Steven A Rosenberg
exaly  

Optimal pain management for patients with cancer in the modern era

Ca-A Cancer Journal for Clinicians, 2018
Cardinale B Smith
exaly  

ERA-Interim: New ECMWF reanalysis products from 1989 onwards

2007
Simmons, Adrian, Uppala, Sakari, Dee, Dick, Kobayashi, Shinya   +3 more
openaire   +1 more source

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein
exaly